Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 E 18th St
1bc
New York, NY 10003Phone+1 212-420-1566Fax+1 212-420-8869
Education & Training
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Urology, 1974 - 1978
- New York-Presbyterian/QueensInternship, Transitional Year, 1973 - 1974
- Nishtar Medical CollegeClass of 1963
Certifications & Licensure
- FL State Medical License 2014 - 2025
- NY State Medical License 1976 - 2018
- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 48 citationsApigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell FunctionsRashida Ginwala, Emily McTish, Chander Raman, Narendra P. Singh, Mitzi Nagarkatti
Journal of Neuroimmune Pharmacology. 2016-03-01 - 13 citationsSchizophrenia: Causes and TreatmentsZafar U. Khan, Elisa Martín-Montañez, E. Chris Muly
Current Pharmaceutical Design. 2013-10-31 - 12 citationsIn vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.Divya Sagar, Shet Masih, Todd D. Schell, Steven Jacobson, Joseph D. Comber
Vaccine. 2014-05-30
Journal Articles
- In Vivo and in Vitro Immunogenicity of Novel MHC Class I Presented Epitopes to Confer Protective Immunity Against Chronic HTLV-1 InfectionZafar K Khan, Pooja Jain, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: